Beranda › Penyakit Sel Sabit › Virginia
Uji klinis Penyakit Sel Sabit di Virginia
9 studi untuk Penyakit Sel Sabit mencari peserta di lokasi di Virginia.
Kota di Virginia
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Inova Health System, Fairfax
- Children's Hsptl Of The Kings, Norfolk
- Virginia Comm Univ Medical Ctr, Richmond
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06612268Early Screening and Treatment of Heart Complication in Sickle Cell Disease
- Inova Schar Cancer, Fairfax
- Inova Health Care Service, Falls Church
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07023666A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Inova Schar Cancer Institute, Fairfax
- Virginia Commonwealth University (VCU) Medical Center, Richmond
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Inova Schar Cancer Institute, Fairfax
Menerima pesertaFase 2/3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Kings Daughters, Norfolk
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Virginia Commonwealth University, Richmond
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Virginia Commonwealth University, Richmond
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- VCU Massey Cancer Center: Dalton Oncology Clinic- Site Number : 8400012, Richmond
Menerima pesertaFase 3
Usia 10 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06975865Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Virginia Commonwealth University, Richmond
Menerima peserta
Usia 16 hingga 30 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT06374238Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.